Skip to main content

Diversification by entry into a new submarket?

Buy Article:

$53.17 plus tax (Refund Policy)


Using a dataset on the subsector and geographical segmentation of 208 Pharmaceutical companies, a Bayesian panel probit is used to analyze the role of state dependency, size and achieved diversification in affecting entry decision. We properly account for unobservable heterogeneity in a context with nonstrictly exogenous regressors. We find that achieved diversification, measured by the number of submarkets already entered affects negatively the probability of entry. Beside some country-specific exceptions, size and the lagged dependent variable do not seem to be relevant.

Keywords: Bayesian inference; C11; C23; C25; L11; L65; diversification; entry; panel data; probit model; random effects

Document Type: Research Article


Affiliations: 1: DG-Research, European Central Bank, Dipartimento di Scienze Economiche,Università di Brescia, Brescia, Italy 2: Dipartimento di Economia,Management e Metodi Quantitativi, Università degli Studi di Milano, Milano, Italy

Publication date: April 1, 2013

More about this publication?

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more